MANUEL
PRAGA TERENTE
Profesor emérito
Mayo Clinic
Rochester, Estados UnidosPublicaciones en colaboración con investigadores/as de Mayo Clinic (10)
2023
-
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Nature Medicine, Vol. 29, Núm. 7, pp. 1867-1876
-
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Journal of the American Society of Nephrology : JASN, Vol. 34, Núm. 6, pp. 955-968
-
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Mayo Clinic Proceedings
-
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Kidney International, Vol. 104, Núm. 6, pp. 1092-1102
2022
-
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
Journal of the American Society of Nephrology : JASN, Vol. 33, Núm. 2, pp. 291-303
2021
-
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
American Journal of Kidney Diseases, Vol. 78, Núm. 3, pp. 340-349.e1
-
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy
Journal of the American Society of Nephrology, Vol. 32, Núm. 2
2017
-
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Kidney International Reports, Vol. 2, Núm. 5, pp. 800-810
2012
-
Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis
Kidney International Supplements, Vol. 2, Núm. 2, pp. 139-274
2004
-
Anti-proteinuric effect of losartan: Statistical vs clinical significance (multiple letters) [1]
Nephrology Dialysis Transplantation